Perspective · 10 Sep 2026
Conference abstractPublished 20 Jul 2015
Prediction of preeclampsia with novel biomarkers at second trimester of pregnancy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: To evaluate the ability of the soluble vascular endothelial growth factor receptor (sFlt-1), neutrophil-flt-1, monocyteflt- 1, pentraxin3 (PTX3), nitric oxide (NO) and alpha fetoprotein (AFP) measurements at gestational weeks 14-18 to predict preeclampsia (PE). Subjects & Methods: Fifty pregnant females at second trimester of pregnancy divided into 25 normotensive pregnant females who remained normotensive till delivery (group I) and 25 high risk pregnant females who subsequently developed PE (group II). Twenty five healthy non-pregnant females served as control (group III). Maternal blood samples were collected at 14-18 gestational weeks. EDTA samples were investigated for both neutrophil- and monocyte-flt-1 by flowcytometer. Stored serum samples were analyzed for sFlt-1, PTX3, NO and AFP by ELISA. Results: Alpha fetoprotein, sflt-1 and pentraxin 3 were found to be statistically significantly increased in group II when compared with group I (P-value = 0.024, < 0.001 & 0.006) and group III (P-value = < 0.001). However, there was statistically significant decrease in neutrophil-flt-1 and nitric oxide in group II when compared with group I (P-value = < 0.001 & 0.016). Group II had significant negative correlation between soluble flt-1 and both neutrophil- & monocyte-flt-1 (P-value = < 0.001 & 0.009) and between neutrophil-flt-1 and PTX3 (P-value = 0.007). Soluble flt-1 was found to have the highest predictive value for predicting preeclampsia (AUC = 0.941& P-value = < 0.001) Conclusion: Soluble flt-1 was the best single biomarker to predict preeclampsia at second trimester of pregnancy with the best diagnostic sensitivity and specificity.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Amal Mahmoud Kamal Eldin”
- BylineArticles whose byline prints “Ahmed Abdel Samie Omran”
- BylineArticles whose byline prints “Ashraf Mohammed Mohammed Osman”
- BylineArticles whose byline prints “Yasser Makram ElSherbeeny”
- BylineArticles whose byline prints “Maged Salah”
- BylineArticles whose byline prints “Ahmed Kotb”
- BylineArticles whose byline prints “Mahmoud Mohammed Moussa”
